Fuqua School of Business and Department of Economics, Duke University, Durham, North Carolina, United States of America.
School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, United States of America.
PLoS Biol. 2019 May 16;17(5):e3000250. doi: 10.1371/journal.pbio.3000250. eCollection 2019 May.
Rapid point-of-care resistance diagnostics (POC-RD) are a key tool in the fight against antibiotic resistance. By tailoring drug choice to infection genotype, doctors can improve treatment efficacy while limiting costs of inappropriate antibiotic prescription. Here, we combine epidemiological theory and data to assess the potential of resistance diagnostics (RD) innovations in a public health context, as a means to limit or even reverse selection for antibiotic resistance. POC-RD can be used to impose a nonbiological fitness cost on resistant strains by enabling diagnostic-informed treatment and targeted interventions that reduce resistant strains' opportunities for transmission. We assess this diagnostic-imposed fitness cost in the context of a spectrum of bacterial population biologies and find that POC-RD have a greater potential against obligate pathogens than opportunistic pathogens already subject to selection under "bystander" antibiotic exposure during asymptomatic carriage (e.g., the pneumococcus). We close by generalizing the notion of RD-informed strategies to incorporate carriage surveillance information and illustrate that coupling transmission-control interventions to the discovery of resistant strains in carriage can potentially select against resistance in a broad range of opportunistic pathogens.
即时床边耐药性诊断(POC-RD)是对抗抗生素耐药性的重要工具。通过根据感染基因型定制药物选择,医生可以提高治疗效果,同时限制不适当的抗生素处方的成本。在这里,我们结合流行病学理论和数据,评估了在公共卫生背景下耐药性诊断(RD)创新的潜力,作为限制甚至逆转抗生素耐药性选择的一种手段。POC-RD 可以通过实施诊断指导的治疗和靶向干预来对耐药菌株施加非生物适应性成本,从而减少耐药菌株传播的机会。我们在一系列细菌种群生物学的背景下评估了这种诊断施加的适应性成本,发现 POC-RD 对抗必需病原体的潜力大于已经在无症状携带期间(例如肺炎球菌)通过“旁观者”抗生素暴露选择的机会性病原体。最后,我们将携带监测信息纳入 RD 知情策略的概念进行推广,并说明将传播控制干预与携带中耐药菌株的发现相结合,有可能在广泛的机会性病原体中选择对抗耐药性。